Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century

Annals of the American Thoracic Society

Volumn 11, Issue 8, 2014, Pages 1176-1185

  Hutchinson, John P ^a   McKeever, Tricia M ^a   Fogarty, Andrew W ^a   Navaratnam, Vidya ^a   Hubbard, Richard B ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Epidemiology; Idiopathic pulmonary fibrosis; Mortality rates

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUSTRALIA; CANADA; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DEATH CERTIFICATE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; ICD-10; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; NEWBORN; SEX DIFFERENCE; SPAIN; SWEDEN; UNITED KINGDOM; UNITED STATES; VALIDITY; CLINICAL TRIAL; FORECASTING; HEALTH; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FORECASTING; GLOBAL HEALTH; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84912122980     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201404-145OC     Document Type: Article

References (21)

1. Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 2011;66:462-467.
2. Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol 2013;5:483-492.
3. Hubbard R, Johnston I, Coultas DB, Britton J. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996;51:711-716.
4. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007;176:277-284.
5. Coultas DB, Hughes MP. Accuracy of mortality data for interstitial lung diseases in New Mexico, USA. Thorax 1996;51:717-720.
6. World Health Organization. International statistical classification of diseases and related health problems, 10th revision, 2010. Available from: http://apps.who.int/classifications/icd10/browse/2010/en
7. Navaratnam V, Fogarty AW, Glendening R, McKeever T, Hubbard RB. The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010. Chest 2013;143:1078-1084.
8. ICD10Data.com. The web's free 2014 ICD-10-CM and ICD-10-PCS medical coding reference [online medical coding guide]. Available from: www.icd10data.com
9. eMedCodes.com. eMedCodes - medical billing and coding lookup [online medical coding guide]. Available from: www.emedcodes.com
10. World Health Organization. International statistical classification of diseases and related health problems, 10th revision, Vol. 2: Instruction manual. Geneva: World Health Organization; 2010.
11. Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979-1991: an analysis of multiple-cause mortality data. Am J Respir Crit Care Med 1996;153:1548-1552.
12. Office for National Statistics. Implementation of the 2013 European Standard Population. Available from: http://www.ons.gov.uk/ons/about-ons/get-involved/consultations/consultations/implementation-of-the-2013-european-standard-population/index.html
13. Navaratnam V, Fogarty AW, McKeever T, Thompson N, Jenkins G, Johnson SR, Dolan G, Kumaran M, Pointon K, Hubbard RB. Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study. Thorax 2014;69:207-215.
14. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
15. Johnston I, Britton J, Kinnear W, Logan R. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990;301:1017-1021.
16. Fell CD, Martinez FJ, Liu LX, Murray S, Han MK, Kazerooni EA, Gross BH, Myers J, Travis WD, Colby TV, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010;181:832-837.
17. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-816.
18. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-1315.
19. Ohno S, Nakaya T, Bando M, Sugiyama Y. Idiopathic pulmonary fibrosis - results from a Japanese nationwide epidemiological survey using individual clinical records. Respirology 2008;13:926-928.
20. Lai CC, Wang CY, Lu HM, Chen L, Teng NC, Yan YH, Wang JY, Chang YT, Chao TT, Lin HI, et al. Idiopathic pulmonary fibrosis in Taiwan - a population-based study. Respir Med 2012;106:1566-1574.
21. Fernández Pérez ER, Daniels CE, Schroeder DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES, Ryu JH. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010;137:129-137.